# GNA13

## Overview
GNA13 is a gene that encodes the G protein subunit alpha 13, a pivotal component of the heterotrimeric G protein complex involved in signal transduction. This protein is categorized as a GTPase, playing a crucial role in the G12/13 family of G-proteins. It is integral to various cellular processes, including the regulation of cytoskeletal dynamics, cell migration, and proliferation, primarily through its activation of Rho GTPases (Inoue2019Illuminating; O’Hayre2015Inactivating). GNA13 is essential for maintaining cellular functions in both physiological and pathological contexts, such as vascular development, immune responses, and tumor suppression. Its interactions with other proteins, such as RhoA and Rho guanine nucleotide exchange factors, underscore its significance in cellular signaling pathways, particularly in the context of cancer and immune system regulation (Muppidi2014Loss; O’Hayre2015Inactivating). The gene's expression and mutations have been implicated in various cancers, highlighting its role in cell invasion and metastasis, as well as in certain developmental disorders (Zhang2015GNA13; Masri2024A).

## Structure
The GNA13 gene encodes the G protein subunit alpha 13, which is part of the heterotrimeric G protein complex involved in signal transduction. The primary structure of GNA13 includes a sequence of 377 amino acids in its longer isoform, with a shorter N-terminus in its alternative isoform due to the use of different 5′ exons (Guo2022Gα12). The secondary structure of GNA13 features an amino-terminal α-helical domain and a Ras-like GTPase domain, which are crucial for its function in binding GDP and GTP (Guo2022Gα12). 

The tertiary structure of GNA13 forms a compact, globular shape, facilitating its role in signal transduction. The quaternary structure involves interaction with Gβ and Gγ subunits, which dissociate upon activation by GTP binding (Guo2022Gα12). Key domains include the GTPase domain, adenylyl cyclase binding site, β-γ complex binding site, and switch regions that undergo conformational changes upon GTP binding (Guo2022Gα12). 

Post-translational modifications such as palmitoylation are essential for GNA13's plasma membrane localization and stability, influencing its tumor suppressor function (Xia2021GNA13). The presence of intrinsically disordered protein regions (IDPRs) in GNA13 may also contribute to its multifunctionality in G protein signaling pathways (Fonin2019Multifunctionality).

## Function
GNA13 encodes the G protein subunit alpha 13, which is a critical component of the G12/13 family of G-proteins involved in signal transduction processes. In healthy human cells, GNA13 plays a significant role in activating Rho GTPases, which are crucial for regulating cytoskeletal dynamics, cell migration, and proliferation (Inoue2019Illuminating; O’Hayre2015Inactivating). This protein is active at the cell membrane, where it transduces signals from G protein-coupled receptors (GPCRs) to downstream effectors, influencing various physiological processes, including vascular development and immune responses (Xia2021GNA13).

In the context of the immune system, GNA13 is essential for maintaining the confinement of germinal center B cells within their niche, preventing their inappropriate migration into circulation. This is achieved through its involvement in the signaling pathway with S1PR2 and ARHGEF1, which represses pAkt signaling and regulates cell migration in response to sphingosine-1-phosphate (Muppidi2014Loss). Additionally, GNA13 negatively regulates BCL2 expression, contributing to its tumor suppressor function in germinal center B-cell-like diffuse large B-cell lymphoma (GCB-DLBCL) cells (Xia2021GNA13). The palmitoylation of GNA13 is crucial for its localization to the plasma membrane and its stability, which are necessary for its role in these cellular processes (Xia2021GNA13).

## Clinical Significance
Mutations and altered expression of the GNA13 gene are implicated in various cancers and conditions. In gastric cancer, GNA13 mutations are frequently observed and are associated with aggressive cancer phenotypes and poor survival outcomes. The gene promotes cell proliferation by influencing the G1-S-phase transition through pathways involving c-Myc and FOXO1 (Zhang2015GNA13). In hepatocellular carcinoma, high GNA13 expression is linked to invasive characteristics and poor prognosis, serving as an independent predictor for shorter overall survival and disease-free survival (Xu2016High).

GNA13 is also involved in breast cancer, where its expression is regulated by microRNAs such as miR-31. Overexpression of GNA13 promotes invasion, while its knockdown inhibits it, suggesting its role in cancer cell invasion and metastasis (Rasheed2015MicroRNA31). In prostate cancer, GNA13 expression is upregulated in aggressive cells, with microRNAs like miR-182 and miR-200a controlling its expression, highlighting its role in cell invasion and migration (Rasheed2013MicroRNA182).

Beyond cancer, a postzygotic mutation in GNA13 is linked to a mosaic skin hypopigmentation syndrome, hypomelanosis of Ito, characterized by developmental anomalies and pigmentary mosaicism due to hyperactivation of the RHOA/ROCK signaling pathway (Masri2024A).

## Interactions
GNA13, or G protein subunit alpha 13, is involved in various cellular signaling pathways through its interactions with other proteins. It primarily interacts with RhoA, a downstream effector, playing a crucial role in the Gα13/RhoA signaling axis. This interaction is significant in the context of certain B cell lymphomas, such as Burkitt's lymphoma and diffuse large B-cell lymphoma (DLBCL), where mutations in GNA13 and RHOA can disrupt this signaling pathway, suggesting a tumor suppressor function (O’Hayre2015Inactivating).

GNA13 also interacts with Rho guanine nucleotide exchange factors (RhoGEFs), which facilitate the activation of RhoA. Mutations in GNA13 can affect its ability to interact with these factors, impacting downstream signaling events (O’Hayre2015Inactivating). The protein's interaction with RhoGEFs is crucial for its role in cell shape and motility, as well as in cancer cell invasion and metastasis (Rasheed2013MicroRNA182).

In addition to its interactions with RhoA and RhoGEFs, GNA13 is involved in signaling pathways that influence cell proliferation and survival, although specific physical interactions with other proteins or nucleic acids in these pathways are not detailed in the provided context (O’Hayre2015Inactivating).


## References


[1. (Xia2021GNA13) Zhizhou Xia, Xiuli Zhang, Ping Liu, Ruihong Zhang, Zhangsen Huang, Donghe Li, Xinhua Xiao, Min Wu, Nannan Ning, Qianqian Zhang, Jianmin Zhang, Mingzhu Liu, Bo Jiao, and Ruibao Ren. Gna13 regulates bcl2 expression and the sensitivity of gcb-dlbcl cells to bcl2 inhibitors in a palmitoylation-dependent manner. Cell Death &amp; Disease, January 2021. URL: http://dx.doi.org/10.1038/s41419-020-03311-1, doi:10.1038/s41419-020-03311-1. This article has 16 citations.](https://doi.org/10.1038/s41419-020-03311-1)

[2. (Zhang2015GNA13) Jia-Xing Zhang, Miao Yun, Yi Xu, Jie-Wei Chen, Hui-Wen Weng, Zou-San Zheng, Cui Chen, Dan Xie, and Sheng Ye. Gna13 as a prognostic factor and mediator of gastric cancer progression. Oncotarget, 7(4):4414–4427, December 2015. URL: http://dx.doi.org/10.18632/oncotarget.6780, doi:10.18632/oncotarget.6780. This article has 32 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.6780)

3. (Masri2024A) A postzygoticGNA13variant upregulates the RHOA/ROCK pathway and alters melanocyte function in a mosaic skin hypopigmentation syndrome. This article has 0 citations.

[4. (O’Hayre2015Inactivating) M O’Hayre, A Inoue, I Kufareva, Z Wang, C M Mikelis, R A Drummond, S Avino, K Finkel, K W Kalim, G DiPasquale, F Guo, J Aoki, Y Zheng, M S Lionakis, A A Molinolo, and J S Gutkind. Inactivating mutations in gna13 and rhoa in burkitt’s lymphoma and diffuse large b-cell lymphoma: a tumor suppressor function for the gα13/rhoa axis in b cells. Oncogene, 35(29):3771–3780, November 2015. URL: http://dx.doi.org/10.1038/onc.2015.442, doi:10.1038/onc.2015.442. This article has 65 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2015.442)

[5. (Rasheed2015MicroRNA31) Suhail Ahmed Kabeer Rasheed, Cui Rong Teo, Emmanuel Jean Beillard, P Mathijs Voorhoeve, Wei Zhou, Sujoy Ghosh, and Patrick J Casey. Microrna-31 controls g protein alpha-13 (gna13) expression and cell invasion in breast cancer cells. Molecular Cancer, March 2015. URL: http://dx.doi.org/10.1186/s12943-015-0337-x, doi:10.1186/s12943-015-0337-x. This article has 62 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/s12943-015-0337-x)

[6. (Inoue2019Illuminating) Asuka Inoue, Francesco Raimondi, Francois Marie Ngako Kadji, Gurdeep Singh, Takayuki Kishi, Akiharu Uwamizu, Yuki Ono, Yuji Shinjo, Satoru Ishida, Nadia Arang, Kouki Kawakami, J. Silvio Gutkind, Junken Aoki, and Robert B. Russell. Illuminating g-protein-coupling selectivity of gpcrs. Cell, 177(7):1933-1947.e25, June 2019. URL: http://dx.doi.org/10.1016/j.cell.2019.04.044, doi:10.1016/j.cell.2019.04.044. This article has 430 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.cell.2019.04.044)

[7. (Muppidi2014Loss) Jagan R. Muppidi, Roland Schmitz, Jesse A. Green, Wenming Xiao, Adrien B. Larsen, Sterling E. Braun, Jinping An, Ying Xu, Andreas Rosenwald, German Ott, Randy D. Gascoyne, Lisa M. Rimsza, Elias Campo, Elaine S. Jaffe, Jan Delabie, Erlend B. Smeland, Rita M. Braziel, Raymond R. Tubbs, J. R. Cook, Dennis D. Weisenburger, Wing C. Chan, Nagarajan Vaidehi, Louis M. Staudt, and Jason G. Cyster. Loss of signalling via gα13 in germinal centre b-cell-derived lymphoma. Nature, 516(7530):254–258, September 2014. URL: http://dx.doi.org/10.1038/nature13765, doi:10.1038/nature13765. This article has 239 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature13765)

[8. (Xu2016High) Yi Xu, Jian Rong, Shiyu Duan, Cui Chen, Yin Li, Baogang Peng, Bin Yi, Zhousan Zheng, Ying Gao, Kebing Wang, Miao Yun, Huiwen Weng, Jiaxing Zhang, and Sheng Ye. High expression of gna13 is associated with poor prognosis in hepatocellular carcinoma. Scientific Reports, November 2016. URL: http://dx.doi.org/10.1038/srep35948, doi:10.1038/srep35948. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep35948)

[9. (Rasheed2013MicroRNA182) Suhail Ahmed Kabeer Rasheed, Cui Rong Teo, Emmanuel Jean Beillard, P.Mathijs Voorhoeve, and Patrick J. Casey. Microrna-182 and microrna-200a control g-protein subunit α-13 (gna13) expression and cell invasion synergistically in prostate cancer cells. Journal of Biological Chemistry, 288(11):7986–7995, March 2013. URL: http://dx.doi.org/10.1074/jbc.M112.437749, doi:10.1074/jbc.m112.437749. This article has 103 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M112.437749)

[10. (Fonin2019Multifunctionality) Alexander V. Fonin, April L. Darling, Irina M. Kuznetsova, Konstantin K. Turoverov, and Vladimir N. Uversky. Multi-functionality of proteins involved in gpcr and g protein signaling: making sense of structure–function continuum with intrinsic disorder-based proteoforms. Cellular and Molecular Life Sciences, 76(22):4461–4492, August 2019. URL: http://dx.doi.org/10.1007/s00018-019-03276-1, doi:10.1007/s00018-019-03276-1. This article has 50 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-019-03276-1)

[11. (Guo2022Gα12) Paipai Guo, Yu Tai, Manman Wang, Hanfei Sun, Lingling Zhang, Wei Wei, Yang K. Xiang, and Qingtong Wang. Gα12 and gα13: versatility in physiology and pathology. Frontiers in Cell and Developmental Biology, February 2022. URL: http://dx.doi.org/10.3389/fcell.2022.809425, doi:10.3389/fcell.2022.809425. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2022.809425)